TYRA - Tyra Biosciences, Inc.
NEXT EARNINGS:
Mar 26, 2026
(in 29 days)
EPS Est: $-0.54
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$49.80
DETAILS
HIGH:
$59.00
LOW:
$42.00
MEDIAN:
$50.00
CONSENSUS:
$49.80
UPSIDE:
46.99%
Market Cap:
1.81B
Volume:
800,284
Avg Volume:
664,959
52 Week Range:
6.42-34.07
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.08
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
60
IPO Date:
2021-09-15
EPS (TTM):
-1.51
P/E Ratio:
-9.20
Revenue (TTM):
N/A
Total Assets:
363.56M
Total Debt:
6.22M
Cash & Equiv:
91.97M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-29.9%
Debt/Equity:
0.02
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-05 | $-0.50 | $-0.50 | 0.0% | — | — | — |
| 2025-08-14 | $-0.47 | $-0.53 | +11.3% | — | — | — |
| 2025-05-08 | $-0.47 | $-0.49 | +4.1% | — | — | — |
| 2025-03-27 | $-0.43 | $-0.48 | +10.4% | — | — | — |
| 2024-11-07 | $-0.41 | $-0.40 | -2.5% | — | — | — |
| 2024-08-07 | $-0.32 | $-0.41 | +22.0% | — | — | — |
| 2024-05-09 | $-0.35 | $-0.46 | +23.9% | — | — | — |
| 2024-03-19 | $-0.53 | $-0.48 | -10.4% | $502000 | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (86.48M) | (69.13M) | (55.33M) | (26.29M) | (9.31M) | (4.06M) |
| EPS | -1.51 | -1.62 | -1.23 | -0.63 | -0.22 | -0.10 |
| Total Assets | 363.56M | 225.86M | 266.18M | 306.70M | 16.01M | 528,000 |
| Total Debt | 6.22M | 6.50M | 2.62M | 1.18M | 142,000 | 253,000 |
| Cash & Equivalents | 91.97M | 58.01M | 251.21M | 302.18M | 15.22M | 108,000 |
| Operating Cash Flow | (69.77M) | (50.14M) | (50.28M) | (23.75M) | (7.76M) | (2.62M) |
| Free Cash Flow | (70.44M) | (50.91M) | (50.84M) | (24.41M) | (8.07M) | (2.64M) |
| FCF per Share | -1.23 | -1.19 | -1.21 | -0.59 | -0.19 | -0.06 |
| Book Value | 343.15M | 204.26M | 257.83M | 301.74M | (13.64M) | (4.74M) |
| Cash & ST Investments | 341.44M | 203.47M | 251.21M | 302.18M | 15.22M | 108,000 |
| ROC Equity | -0.25 | -0.34 | -0.21 | -0.09 | N/A | N/A |